CIP2A and Miyoshi myopathy: Survival analysis revealed that MM patients with high CIP2A expression (n=19) presented with a poorer overall survival than those with low CIP2A expression (n=22; P=0.033; Figure 1j) And, the median survival of low and high CIP2A groups were 66 and 45 months, respectively.